BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cijauskaite E, Kazenaite E, Strainiene S, Sadauskaite G, Kurlinkus B. Nivolumab-induced tumour-like gastritis: A case report. World J Clin Cases 2023; 11(18): 4350-4359 [PMID: 37449232 DOI: 10.12998/wjcc.v11.i18.4350]
URL: https://www.wjgnet.com/1007-9327/full/v11/i18/4350.htm
Number Citing Articles
1
Haibo Lei, Wei Sun, Xiang Liu, Chunjiang Wang. Clinical Characteristics and Outcomes of Pembrolizumab Induced Gastritis: A Systematic Review of the LiteratureJournal of Gastrointestinal Cancer 2024; 55(3): 1 doi: 10.1007/s12029-024-01067-x
2
NivolumabReactions Weekly 2023; 1975(1): 294 doi: 10.1007/s40278-023-46649-1
3
Radhika V. Kumar, Boris Zhang, Manoranjan S. D'Souza, Sidhartha D. Ray. Side Effects of Drugs Annual 2023; 45: 507 doi: 10.1016/bs.seda.2023.09.004